Hydrocortisone Sodium Succinate

Especificaciones

125-04-2Número CAS

204-725-5Número CE

sodium 4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoateNombre IUPAC

C25H33NaO8Fórmula química

484.5 g/molPeso molecular

Hydrocortisone sodium succinate; 125-04-2; A-hydroCort; Solu-Cortef; Nositrol; Cortop; Cortisol 21-(sodium succinate); Flebocortid; Buccalsone; Hycorace; Nordicort; Solu-Glyc; Cortisol sodium succinate; Hydrocortisone 21-sodium succinate; Sodium hydrocortisone succinate; 50LQB69S1Z; NSC-9152; Hydrocortisoni natrii succinas; NSC9152; Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)-; Sinsurrene; Kinogen; Hidroc Clora; Emergent-EZ; RefChem:55353; Hydrocortisone Na Succinate; (11beta)-21-(3-Carboxy-1-oxopropyl)-11,17-dihydroxypregn-4-ene-3,20-dione, Monosodium Salt; Efcortelan; Hydrocortisone 21-hemisuccinate sodium salt; Corlan; Arcocort; Intracort; Oralsone; Hydrocortisone hemisuccinate sodium salt; DTXSID2049006; Emi-Corlin; Solu-Hizon; Hydrocortisone sodium hemisuccinate; EF-Cortelan soluble; Cortisol sodium hemisuccinate; Hydrocortisone hemisuccinate (sodium); Cortisol hemisuccinate sodium salt; Hydrocortisone 21-sodium succinide; Sodium hydrocortisone 21-succinate; Hydrocortisone 21-hemisuccinate sodium; Hydrocortisone sodium 21-hemisuccinate; Sodium hydrocortisone 21-hemisuccinate; Hydrocortisone 21-succinate sodium salt; DTXCID7028932; Sodium 17-hydroxycorticosterone 21-succinate; Hidrokortizon; U 4905; Rapicort; Lycortin-S; CAS-125-04-2; Flebocortid [inj.]; Hydro-Adreson aquosum; NCGC00022248-03; Idrocortisone B. I. L.; UNII-50LQB69S1Z; C25H33NaO8; Hydrocortisone succinate,sodium salt; EINECS 204-725-5; A-hydrocort (TN); Solu-cortef (TN); Hydrocortisone 21-(sodium succinate); Hydrocortisone-21-hemisuccinate sodium; Hydrocortisone-21-hemisuccinate sodium salt; 3-{[2-((1S,10S,11S,15S,17S,2R,14R)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyc lo[8.7.0.0<2,7>.0<11,15>]heptadec-6-en-14-yl)-2-oxoethyl]oxycarbonyl}propanoic acid, sodium salt; Hydrocortisone sodium succinate [USP:BAN:JAN]; Cortisol hemisuccinate sodium; SCHEMBL93508; MLS000069545; CHEBI:5782; CHEMBL1200495; Cortisol 21-hemisuccinate sodium; HY-B1402B; HHZQLQREDATOBM-CODXZCKSSA-M; Hydrocortisone hemisuccinate sodium; HMS2234H22; Tox21_113501; AKOS024386298; Tox21_113501_1; FH23889; CORTISOL, SUCCINATE, SODIUM SALT; NCGC00022248-04; DA-52057; Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11.beta.)-; SMR000058768; CORTISOL 21-HEMISUCCINATE SODIUM SALT; CS-0030896; EU-0100623; Hydrocortisone sodium succinate (JP18/USP); HYDROCORTISONE SODIUM SUCCINATE [JAN]; ST51037298; U4905; C08178; D00978; F20569; H 2270; HYDROCORTISONE SODIUM SUCCINATE [MART.]; HYDROCORTISONE SODIUM SUCCINATE [VANDF]; HYDROCORTISONE 21-SODIUM SUCCINATE [MI]; HYDROCORTISONE SODIUM SUCCINATE [WHO-DD]; HYDROCORTISONE SODIUM SUCCINATE [WHO-IP]; Cortisol, 21-(hydrogen succinate), monosodium salt; HYDROCORTISONE SODIUM SUCCINATE [ORANGE BOOK]; HYDROCORTISONE SODIUM SUCCINATE [USP MONOGRAPH]; HYDROCORTISONI NATRII SUCCINAS [WHO-IP LATIN]; Q27106890; Hydrocortisone 21-hemisuccinate sodium salt, >=90% (HPLC); 21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxy-pregn-4-ene-3,20-dione sodium; Hydrocortisone 21-hemisuccinate sodium salt, powder, BioReagent, suitable for cell culture; Sodium 4-[(11beta,17-dihydroxy-3,20-dioxopregn-4-en-21-yl)oxy]-4-oxobutanoate; (11beta)-21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxypregn-14-ene-3,20-dione, Monosodium salt; sodium;4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethoxy]-4-oxo-butanoate; sodium;4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate; Hydrocortisone Natri SuccinateSinónimos